Upgrade to SI Premium - Free Trial

Collegium Pharma (COLL)

34.80 +0.40 (1.16%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 COLLEGIUM PHARMACEUTICAL For: Jun 08 Filed by: SANTINI GINO June 10, 2026 4:10 PM - SEC Filing Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 5, 2026 8:00 AM - StreetInsider Form S-8 COLLEGIUM PHARMACEUTICAL June 1, 2026 4:48 PM - SEC Filing Form S-8 COLLEGIUM PHARMACEUTICAL June 1, 2026 4:47 PM - SEC Filing Collegium to Participate in 2026 Jefferies Global Healthcare Conference May 27, 2026 8:00 AM - Globe NewsWire Form 4 COLLEGIUM PHARMACEUTICAL For: May 18 Filed by: Freund John Gordon May 20, 2026 4:05 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: BOHLIN GAREN G May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Paya Carlos V May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Lurker Nancy May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Freund John Gordon May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Balice-Gordon Rita J. May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: SANTINI GINO May 18, 2026 4:25 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Glancy Donovan Michael May 18, 2026 4:25 PM - SEC Filing Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Freund John Gordon May 18, 2026 4:08 PM - SEC Filing Form 3 COLLEGIUM PHARMACEUTICAL For: May 14 Filed by: Glancy Donovan Michael May 18, 2026 4:03 PM - SEC Filing Form 8-K COLLEGIUM PHARMACEUTICAL For: May 14 May 15, 2026 4:16 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 13 Filed by: Lurker Nancy May 15, 2026 4:08 PM - SEC Filing Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 11:43 AM - SEC Filing Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: EVENTIDE ASSET MANAGEMENT, LLC May 15, 2026 11:34 AM - SEC Filing Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Freund John Gordon May 15, 2026 10:51 AM - SEC Filing Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: RENAISSANCE TECHNOLOGIES LLC May 14, 2026 4:46 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: May 11 Filed by: BOHLIN GAREN G May 13, 2026 4:05 PM - SEC Filing Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Lurker Nancy May 13, 2026 12:09 PM - SEC Filing Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: INTEGRATED CORE STRATEGIES (US) LLC May 12, 2026 5:55 PM - SEC Filing Form 8-K COLLEGIUM PHARMACEUTICAL For: May 12 May 12, 2026 7:44 AM - SEC Filing Collegium Pharmaceutical completes $650 million AZSTARYS acquisition May 12, 2026 7:32 AM - StreetInsider Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics May 12, 2026 7:31 AM - Globe NewsWire Form 144 COLLEGIUM PHARMACEUTICAL Filed by: BOHLIN GAREN G May 11, 2026 11:39 AM - SEC Filing Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: Invesco Ltd. May 8, 2026 10:17 AM - SEC Filing Collegium Pharmaceutical (COLL) PT Raised to $45 at Piper Sandler May 7, 2026 2:14 PM - StreetInsider Collegium Pharma (COLL) Tops Q1 EPS by 13c ; Offers Guidance May 7, 2026 7:41 AM - StreetInsider Form 10-Q COLLEGIUM PHARMACEUTICAL For: Mar 31 May 7, 2026 7:35 AM - SEC Filing Form 8-K COLLEGIUM PHARMACEUTICAL For: May 07 May 7, 2026 7:33 AM - SEC Filing Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress May 7, 2026 7:30 AM - Globe NewsWire Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 April 23, 2026 8:02 AM - Globe NewsWire Truist: 'We like the risk/reward setup for Collegium Pharmaceutical (COLL)' April 16, 2026 9:03 AM - StreetInsider Collegium to Participate in Upcoming Investor Conferences April 8, 2026 8:00 AM - Globe NewsWire Form ARS COLLEGIUM PHARMACEUTICAL For: Dec 31 April 7, 2026 4:20 PM - SEC Filing Form DEF 14A COLLEGIUM PHARMACEUTICAL For: May 14 April 7, 2026 4:03 PM - SEC Filing Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 02 April 7, 2026 4:02 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 17 Filed by: Dieter David April 3, 2026 4:47 PM - SEC Filing Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: VANGUARD GROUP INC March 26, 2026 5:43 PM - SEC Filing Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 18 Filed by: Dieter David March 20, 2026 5:15 PM - SEC Filing Jefferies likes Collegium Pharmaceutical (COLL) Azstarys acquisition March 19, 2026 5:28 PM - StreetInsider Form 8-K COLLEGIUM PHARMACEUTICAL For: Mar 19 March 19, 2026 5:07 PM - SEC Filing Barclays on Collegium Pharmaceutical (COLL): 'we would add to positions at this level' March 19, 2026 12:45 PM - StreetInsider Collegium to acquire AZSTARYS from Corium for $650 million March 19, 2026 8:00 AM - StreetInsider Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory March 19, 2026 8:00 AM - StreetInsider Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David March 18, 2026 4:11 PM - SEC Filing Full Article List